PharmiWeb.com - Global Pharma News & Resources
31-Jan-2019

Zenyth Partners Launches Healthcare-Focused Permanent Capital Vehicle

GREAT NECK, N.Y., Jan. 30, 2019 /PRNewswire/ -- Zenyth Partners, an operationally-focused healthcare investment firm, today announced that it successfully launched a new permanent capital vehicle created to build innovative consumer-facing healthcare services companies.

Zenyth will partner with entrepreneurial leaders to grow organizations and create value for stakeholders. In addition to providing capital for expansion, Zenyth's investment and operating professionals will draw on their many years of experience and a deep resource network to offer hands-on strategic and operational support to healthcare entrepreneurs.

"Rising costs and the consumerization of healthcare are driving massive industry transformation.  We want to be a part of the solution to improve delivery of and access to care while lowering costs," said Rob Feuer, Managing Partner, Zenyth Partners.

Zenyth will strategically partner with organizations that prioritize patient care to grow and increase access to high quality healthcare services while relieving administrative burdens that take away from medical professionals' clinical time.

"At Zenyth, we believe that patient care comes first and core to our investing strategy is working with organizations with high standards of clinical care," added Feuer. "Our goal is to be known within the healthcare community as a mission-driven partner that supports providers to deliver the best possible care to their patients."

By securing permanent capital, Zenyth will be able to establish lasting partnerships centered around building sustainable healthcare organizations and ensure success for all stakeholders: patients, clinicians and administrative staff.

"Unlike investment firms that are structured to pursue short-term exits or additional capital, we focus on cultivating long-term partnerships with providers and payors to deliver the best and most economical care strategies possible," said Sean Hayes, Partner, Zenyth Partners. "Our new permanent capital vehicle fits that strategy and positions us to provide ongoing financial and operational support to help fuel the growth of our partner organizations."

"Zenyth's operationally focused, hands on approach helps us build our business every day," said Phil Toh, CEO of The Smilist Management. "Having that level of support and expertise in building consumer-oriented healthcare businesses has been invaluable as we work to scale the Smilist and build a market-leading dental service organization."

RenalCare Options CEO Joseph Cashia commented, "Zenyth's deep expertise in growing multi-unit businesses, along with their ability to bring exceptional resources to bear, will be great assets as we seek to expand our business model into geographically dispersed regions while continuing to drive robust growth in our core markets."

"Zenyth has a truly unique approach to investment in the healthcare sector. Its focus on smart, long-term growth and its philosophy of nurturing and developing its physicians and staff resonate very well in the industry," said Dan Doman, CEO of Refocus Eye Health.

Debevoise & Plimpton served as legal counsel to Zenyth.

About Zenyth Partners

Zenyth Partners is an investment firm focused on building leading healthcare organizations. Zenyth has been active building healthcare businesses including The Smilist Management, Schweiger Dermatology Group, ReFocus Eye Health and RenalCare Options. Zenyth seeks to invest up to $35 million in each opportunity with the potential to invest more capital in the appropriate circumstances. For more information, visit www.zenythpartners.com.

Editor Details

Related Links

Last Updated: 31-Jan-2019